Ignite Creation Date:
2024-05-06 @ 3:52 PM
Last Modification Date:
2024-10-26 @ 1:59 PM
Study NCT ID:
NCT04789096
Status:
RECRUITING
Last Update Posted:
2024-06-21
First Post:
2021-03-01
Brief Title:
Tucatinib Together With Pembrolizumab and Trastuzumab
Sponsor:
Breast Cancer Trials Australia and New Zealand
Organization:
Breast Cancer Trials Australia and New Zealand
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-03-07
Start Date Type:
ACTUAL
Primary Completion Date:
2024-09-30
Primary Completion Date Type:
ESTIMATED
Completion Date:
2025-09
Completion Date Type:
ESTIMATED
First Submit Date:
2021-03-01
First Submit QC Date:
March 7 2021
Study First Post Date:
2021-03-09
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-06-20
Last Update Post Date:
2024-06-21
Last Update Post Date Type:
ACTUAL